Maria Lyng
Odense University Hospital(DK)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Estrogen and related hormone effects, HER2/EGFR in Cancer Research, Multiple Myeloma Research and Treatments, MicroRNA in disease regulation
Most-Cited Works
- → CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial(2012)338 cited
- → Novel circulating microRNA signature as a potential non‐invasive multi‐marker test in ER‐positive early‐stage breast cancer: A case control study(2014)187 cited
- → Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence(2017)156 cited
- → Identification of genes for normalization of real-time RT-PCR data in breast carcinomas(2008)113 cited
- → The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer(2012)96 cited
- → High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer(2016)76 cited
- → Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors(2009)72 cited
- → Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study(2012)60 cited
- → SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer(2018)44 cited
- → Coexisting genomic aberrations associated with lymph node metastasis in breast cancer(2018)41 cited